ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Humanized Antibody Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-23B5612
Home | Market Reports | Science| Biological Sciences
Global Humanized Antibody Market Insights Forecast to 2028
BUY CHAPTERS

Global Humanized Antibody Market Research Report 2025

Code: QYRE-Auto-23B5612
Report
June 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
MorphoSys
Huston BioConsulting LLC
Seattle Genetics
Zyngenia
Genentech Inc
ImmunoGen Inc
Sandoz International
MRC Laboratory of Molecular Biology

Humanized Antibody Market Size

The global market for Humanized Antibody was valued at US$ 241 million in the year 2024 and is projected to reach a revised size of US$ 407 million by 2031, growing at a CAGR of 7.9% during the forecast period.

Humanized Antibody Market

Humanized Antibody Market

Humanized antibodies mainly refer to antibodies re-expressed by gene cloning and DNA recombination technology of mouse monoclonal antibodies, most of the amino acid sequences of which are replaced by human sequences, and reducing the Its heterogeneity is beneficial to the human body.The constant region part (ie, CH and CL regions) of humanized antibody are encoded by human antibody genes. Human antibodies can greatly reduce the immune side effects of heterologous antibodies on the human body.
The humanized antibody market was witnessing steady growth, primarily due to the rising demand for targeted therapies in the treatment of cancer, autoimmune diseases, and other medical conditions. The market featured a mix of large pharmaceutical companies, biotechnology firms, and specialized antibody developers. Major players like Roche, Novartis, and Johnson & Johnson were actively involved in the development and commercialization of humanized antibodies. Opportunities existed for humanized antibodies in the field of oncology, where targeted therapies were gaining prominence. There was a growing focus on using humanized antibodies to treat autoimmune diseases like rheumatoid arthritis and multiple sclerosis.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Humanized Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Humanized Antibody.
The Humanized Antibody market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Humanized Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Humanized Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Humanized Antibody Market Report

Report Metric Details
Report Name Humanized Antibody Market
Accounted market size in year US$ 241 million
Forecasted market size in 2031 US$ 407 million
CAGR 7.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Chimeric Antibody
  • Modified Antibody
Segment by Application
  • Laboratory Research
  • Clinical Drugs
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amgen, MorphoSys, Huston BioConsulting LLC, Seattle Genetics, Zyngenia, Genentech, ImmunoGen, Sandoz International, MRC Laboratory of Molecular Biology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Humanized Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Humanized Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Humanized Antibody Market growing?

Ans: The Humanized Antibody Market witnessing a CAGR of 7.9% during the forecast period 2025-2031.

What is the Humanized Antibody Market size in 2031?

Ans: The Humanized Antibody Market size in 2031 will be US$ 407 million.

Who are the main players in the Humanized Antibody Market report?

Ans: The main players in the Humanized Antibody Market are Amgen, MorphoSys, Huston BioConsulting LLC, Seattle Genetics, Zyngenia, Genentech, ImmunoGen, Sandoz International, MRC Laboratory of Molecular Biology

What are the Application segmentation covered in the Humanized Antibody Market report?

Ans: The Applications covered in the Humanized Antibody Market report are Laboratory Research, Clinical Drugs

What are the Type segmentation covered in the Humanized Antibody Market report?

Ans: The Types covered in the Humanized Antibody Market report are Chimeric Antibody, Modified Antibody

1 Humanized Antibody Market Overview
1.1 Product Definition
1.2 Humanized Antibody by Type
1.2.1 Global Humanized Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Chimeric Antibody
1.2.3 Modified Antibody
1.3 Humanized Antibody by Application
1.3.1 Global Humanized Antibody Market Value by Application (2024 VS 2031)
1.3.2 Laboratory Research
1.3.3 Clinical Drugs
1.4 Global Humanized Antibody Market Size Estimates and Forecasts
1.4.1 Global Humanized Antibody Revenue 2020-2031
1.4.2 Global Humanized Antibody Sales 2020-2031
1.4.3 Global Humanized Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Humanized Antibody Market Competition by Manufacturers
2.1 Global Humanized Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global Humanized Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Humanized Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Humanized Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Humanized Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Humanized Antibody, Product Type & Application
2.7 Global Key Manufacturers of Humanized Antibody, Date of Enter into This Industry
2.8 Global Humanized Antibody Market Competitive Situation and Trends
2.8.1 Global Humanized Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Humanized Antibody Players Market Share by Revenue
2.8.3 Global Humanized Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Humanized Antibody Market Scenario by Region
3.1 Global Humanized Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Humanized Antibody Sales by Region: 2020-2031
3.2.1 Global Humanized Antibody Sales by Region: 2020-2025
3.2.2 Global Humanized Antibody Sales by Region: 2026-2031
3.3 Global Humanized Antibody Revenue by Region: 2020-2031
3.3.1 Global Humanized Antibody Revenue by Region: 2020-2025
3.3.2 Global Humanized Antibody Revenue by Region: 2026-2031
3.4 North America Humanized Antibody Market Facts & Figures by Country
3.4.1 North America Humanized Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Humanized Antibody Sales by Country (2020-2031)
3.4.3 North America Humanized Antibody Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Humanized Antibody Market Facts & Figures by Country
3.5.1 Europe Humanized Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Humanized Antibody Sales by Country (2020-2031)
3.5.3 Europe Humanized Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Humanized Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Humanized Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Humanized Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific Humanized Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Humanized Antibody Market Facts & Figures by Country
3.7.1 Latin America Humanized Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Humanized Antibody Sales by Country (2020-2031)
3.7.3 Latin America Humanized Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Humanized Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Humanized Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Humanized Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa Humanized Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Humanized Antibody Sales by Type (2020-2031)
4.1.1 Global Humanized Antibody Sales by Type (2020-2025)
4.1.2 Global Humanized Antibody Sales by Type (2026-2031)
4.1.3 Global Humanized Antibody Sales Market Share by Type (2020-2031)
4.2 Global Humanized Antibody Revenue by Type (2020-2031)
4.2.1 Global Humanized Antibody Revenue by Type (2020-2025)
4.2.2 Global Humanized Antibody Revenue by Type (2026-2031)
4.2.3 Global Humanized Antibody Revenue Market Share by Type (2020-2031)
4.3 Global Humanized Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global Humanized Antibody Sales by Application (2020-2031)
5.1.1 Global Humanized Antibody Sales by Application (2020-2025)
5.1.2 Global Humanized Antibody Sales by Application (2026-2031)
5.1.3 Global Humanized Antibody Sales Market Share by Application (2020-2031)
5.2 Global Humanized Antibody Revenue by Application (2020-2031)
5.2.1 Global Humanized Antibody Revenue by Application (2020-2025)
5.2.2 Global Humanized Antibody Revenue by Application (2026-2031)
5.2.3 Global Humanized Antibody Revenue Market Share by Application (2020-2031)
5.3 Global Humanized Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Company Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Humanized Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amgen Humanized Antibody Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 MorphoSys
6.2.1 MorphoSys Company Information
6.2.2 MorphoSys Description and Business Overview
6.2.3 MorphoSys Humanized Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 MorphoSys Humanized Antibody Product Portfolio
6.2.5 MorphoSys Recent Developments/Updates
6.3 Huston BioConsulting LLC
6.3.1 Huston BioConsulting LLC Company Information
6.3.2 Huston BioConsulting LLC Description and Business Overview
6.3.3 Huston BioConsulting LLC Humanized Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Huston BioConsulting LLC Humanized Antibody Product Portfolio
6.3.5 Huston BioConsulting LLC Recent Developments/Updates
6.4 Seattle Genetics
6.4.1 Seattle Genetics Company Information
6.4.2 Seattle Genetics Description and Business Overview
6.4.3 Seattle Genetics Humanized Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Seattle Genetics Humanized Antibody Product Portfolio
6.4.5 Seattle Genetics Recent Developments/Updates
6.5 Zyngenia
6.5.1 Zyngenia Company Information
6.5.2 Zyngenia Description and Business Overview
6.5.3 Zyngenia Humanized Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zyngenia Humanized Antibody Product Portfolio
6.5.5 Zyngenia Recent Developments/Updates
6.6 Genentech
6.6.1 Genentech Company Information
6.6.2 Genentech Description and Business Overview
6.6.3 Genentech Humanized Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Genentech Humanized Antibody Product Portfolio
6.6.5 Genentech Recent Developments/Updates
6.7 ImmunoGen
6.7.1 ImmunoGen Company Information
6.7.2 ImmunoGen Description and Business Overview
6.7.3 ImmunoGen Humanized Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ImmunoGen Humanized Antibody Product Portfolio
6.7.5 ImmunoGen Recent Developments/Updates
6.8 Sandoz International
6.8.1 Sandoz International Company Information
6.8.2 Sandoz International Description and Business Overview
6.8.3 Sandoz International Humanized Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sandoz International Humanized Antibody Product Portfolio
6.8.5 Sandoz International Recent Developments/Updates
6.9 MRC Laboratory of Molecular Biology
6.9.1 MRC Laboratory of Molecular Biology Company Information
6.9.2 MRC Laboratory of Molecular Biology Description and Business Overview
6.9.3 MRC Laboratory of Molecular Biology Humanized Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 MRC Laboratory of Molecular Biology Humanized Antibody Product Portfolio
6.9.5 MRC Laboratory of Molecular Biology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Humanized Antibody Industry Chain Analysis
7.2 Humanized Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Humanized Antibody Production Mode & Process Analysis
7.4 Humanized Antibody Sales and Marketing
7.4.1 Humanized Antibody Sales Channels
7.4.2 Humanized Antibody Distributors
7.5 Humanized Antibody Customer Analysis
8 Humanized Antibody Market Dynamics
8.1 Humanized Antibody Industry Trends
8.2 Humanized Antibody Market Drivers
8.3 Humanized Antibody Market Challenges
8.4 Humanized Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Amgen Inc
MorphoSys
Huston BioConsulting LLC
Seattle Genetics
Zyngenia
Genentech Inc
ImmunoGen Inc
Sandoz International
MRC Laboratory of Molecular Biology
List of Tables
 Table 1. Global Humanized Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Humanized Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Humanized Antibody Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Humanized Antibody Sales (Kg) of Key Manufacturers (2020-2025)
 Table 5. Global Humanized Antibody Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Humanized Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Humanized Antibody Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Humanized Antibody Average Price (US$/g) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Humanized Antibody, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Humanized Antibody, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Humanized Antibody, Product Type & Application
 Table 12. Global Key Manufacturers of Humanized Antibody, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Humanized Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humanized Antibody as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Humanized Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Humanized Antibody Sales by Region (2020-2025) & (Kg)
 Table 18. Global Humanized Antibody Sales Market Share by Region (2020-2025)
 Table 19. Global Humanized Antibody Sales by Region (2026-2031) & (Kg)
 Table 20. Global Humanized Antibody Sales Market Share by Region (2026-2031)
 Table 21. Global Humanized Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Humanized Antibody Revenue Market Share by Region (2020-2025)
 Table 23. Global Humanized Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Humanized Antibody Revenue Market Share by Region (2026-2031)
 Table 25. North America Humanized Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Humanized Antibody Sales by Country (2020-2025) & (Kg)
 Table 27. North America Humanized Antibody Sales by Country (2026-2031) & (Kg)
 Table 28. North America Humanized Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Humanized Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Humanized Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Humanized Antibody Sales by Country (2020-2025) & (Kg)
 Table 32. Europe Humanized Antibody Sales by Country (2026-2031) & (Kg)
 Table 33. Europe Humanized Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Humanized Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Humanized Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Humanized Antibody Sales by Region (2020-2025) & (Kg)
 Table 37. Asia Pacific Humanized Antibody Sales by Region (2026-2031) & (Kg)
 Table 38. Asia Pacific Humanized Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Humanized Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Humanized Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Humanized Antibody Sales by Country (2020-2025) & (Kg)
 Table 42. Latin America Humanized Antibody Sales by Country (2026-2031) & (Kg)
 Table 43. Latin America Humanized Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Humanized Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Humanized Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Humanized Antibody Sales by Country (2020-2025) & (Kg)
 Table 47. Middle East and Africa Humanized Antibody Sales by Country (2026-2031) & (Kg)
 Table 48. Middle East and Africa Humanized Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Humanized Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Humanized Antibody Sales (Kg) by Type (2020-2025)
 Table 51. Global Humanized Antibody Sales (Kg) by Type (2026-2031)
 Table 52. Global Humanized Antibody Sales Market Share by Type (2020-2025)
 Table 53. Global Humanized Antibody Sales Market Share by Type (2026-2031)
 Table 54. Global Humanized Antibody Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Humanized Antibody Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Humanized Antibody Revenue Market Share by Type (2020-2025)
 Table 57. Global Humanized Antibody Revenue Market Share by Type (2026-2031)
 Table 58. Global Humanized Antibody Price (US$/g) by Type (2020-2025)
 Table 59. Global Humanized Antibody Price (US$/g) by Type (2026-2031)
 Table 60. Global Humanized Antibody Sales (Kg) by Application (2020-2025)
 Table 61. Global Humanized Antibody Sales (Kg) by Application (2026-2031)
 Table 62. Global Humanized Antibody Sales Market Share by Application (2020-2025)
 Table 63. Global Humanized Antibody Sales Market Share by Application (2026-2031)
 Table 64. Global Humanized Antibody Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Humanized Antibody Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Humanized Antibody Revenue Market Share by Application (2020-2025)
 Table 67. Global Humanized Antibody Revenue Market Share by Application (2026-2031)
 Table 68. Global Humanized Antibody Price (US$/g) by Application (2020-2025)
 Table 69. Global Humanized Antibody Price (US$/g) by Application (2026-2031)
 Table 70. Amgen Company Information
 Table 71. Amgen Description and Business Overview
 Table 72. Amgen Humanized Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 73. Amgen Humanized Antibody Product
 Table 74. Amgen Recent Developments/Updates
 Table 75. MorphoSys Company Information
 Table 76. MorphoSys Description and Business Overview
 Table 77. MorphoSys Humanized Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 78. MorphoSys Humanized Antibody Product
 Table 79. MorphoSys Recent Developments/Updates
 Table 80. Huston BioConsulting LLC Company Information
 Table 81. Huston BioConsulting LLC Description and Business Overview
 Table 82. Huston BioConsulting LLC Humanized Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 83. Huston BioConsulting LLC Humanized Antibody Product
 Table 84. Huston BioConsulting LLC Recent Developments/Updates
 Table 85. Seattle Genetics Company Information
 Table 86. Seattle Genetics Description and Business Overview
 Table 87. Seattle Genetics Humanized Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 88. Seattle Genetics Humanized Antibody Product
 Table 89. Seattle Genetics Recent Developments/Updates
 Table 90. Zyngenia Company Information
 Table 91. Zyngenia Description and Business Overview
 Table 92. Zyngenia Humanized Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 93. Zyngenia Humanized Antibody Product
 Table 94. Zyngenia Recent Developments/Updates
 Table 95. Genentech Company Information
 Table 96. Genentech Description and Business Overview
 Table 97. Genentech Humanized Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 98. Genentech Humanized Antibody Product
 Table 99. Genentech Recent Developments/Updates
 Table 100. ImmunoGen Company Information
 Table 101. ImmunoGen Description and Business Overview
 Table 102. ImmunoGen Humanized Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 103. ImmunoGen Humanized Antibody Product
 Table 104. ImmunoGen Recent Developments/Updates
 Table 105. Sandoz International Company Information
 Table 106. Sandoz International Description and Business Overview
 Table 107. Sandoz International Humanized Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 108. Sandoz International Humanized Antibody Product
 Table 109. Sandoz International Recent Developments/Updates
 Table 110. MRC Laboratory of Molecular Biology Company Information
 Table 111. MRC Laboratory of Molecular Biology Description and Business Overview
 Table 112. MRC Laboratory of Molecular Biology Humanized Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 113. MRC Laboratory of Molecular Biology Humanized Antibody Product
 Table 114. MRC Laboratory of Molecular Biology Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Humanized Antibody Distributors List
 Table 118. Humanized Antibody Customers List
 Table 119. Humanized Antibody Market Trends
 Table 120. Humanized Antibody Market Drivers
 Table 121. Humanized Antibody Market Challenges
 Table 122. Humanized Antibody Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Humanized Antibody
 Figure 2. Global Humanized Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Humanized Antibody Market Share by Type: 2024 & 2031
 Figure 4. Chimeric Antibody Product Picture
 Figure 5. Modified Antibody Product Picture
 Figure 6. Global Humanized Antibody Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Humanized Antibody Market Share by Application: 2024 & 2031
 Figure 8. Laboratory Research
 Figure 9. Clinical Drugs
 Figure 10. Global Humanized Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Humanized Antibody Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Humanized Antibody Sales (2020-2031) & (Kg)
 Figure 13. Global Humanized Antibody Average Price (US$/g) & (2020-2031)
 Figure 14. Humanized Antibody Report Years Considered
 Figure 15. Humanized Antibody Sales Share by Manufacturers in 2024
 Figure 16. Global Humanized Antibody Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Humanized Antibody Players: Market Share by Revenue in Humanized Antibody in 2024
 Figure 18. Humanized Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Humanized Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Humanized Antibody Sales Market Share by Country (2020-2031)
 Figure 21. North America Humanized Antibody Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Humanized Antibody Sales Market Share by Country (2020-2031)
 Figure 25. Europe Humanized Antibody Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Humanized Antibody Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Humanized Antibody Revenue Market Share by Region (2020-2031)
 Figure 33. China Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Humanized Antibody Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Humanized Antibody Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Humanized Antibody Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Humanized Antibody Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Humanized Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Humanized Antibody by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Humanized Antibody by Type (2020-2031)
 Figure 55. Global Humanized Antibody Price (US$/g) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Humanized Antibody by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Humanized Antibody by Application (2020-2031)
 Figure 58. Global Humanized Antibody Price (US$/g) by Application (2020-2031)
 Figure 59. Humanized Antibody Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Humanized Monoclonal Antibody Market Research Report 2024
Global Fully Humanized Monoclonal Antibody Market Research Report 2024
Global Humanized Bispecific Antibody Market Research Report 2024
Global Humanized Bispecific Antibodies Market Research Report 2024
Fully Humanized Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antibody Humanization Market Research Report 2025
Global Recombinant Antibody Market Research Report 2025
Global Humanized Mouse Model Market Research Report 2024
Global Recombinant Rabbit Monoclonal Antibodies Market Research Report 2025
Global Therapeutic Monoclonal Antibodies Market Research Report 2024
Global Antibody Library Technology Market Research Report 2024
Humanized Mouse and Rat Model Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024
Global Mouse Antibody Market Research Report 2024
Monoclonal Antibody Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biologics Monoclonal Antibodies Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Monoclonal Antibody Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biosimilar Antibodies Market Research Report 2024
Global Research Grade Antibodies Market Research Report 2024
Global Tetanus Human Monoclonal Antibody Market Research Report 2024

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions